VIEMED HEALTHCARE, INC. shareholders approved Advisory vote on executive compensation.
“Shareholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers (the “say-on-pay” vote).”
VIEMED HEALTHCARE, INC. — fact timeline
Source-grounded facts extracted from VIEMED HEALTHCARE, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
VIEMED HEALTHCARE, INC. shareholders approved Ratification of Second Amendment to the 2024 LTIP.
“Shareholders approved an ordinary resolution to ratify, confirm, and approve the Second Amendment to the 2024 LTIP.”
VIEMED HEALTHCARE, INC. shareholders approved Appointment of Ernst & Young LLP as independent auditors at the 2026-12-31 meeting.
“Shareholders approved the appointment of Ernst & Young LLP as the Company’s independent auditors for the fiscal year ending December 31, 2026, and authorized the Company's Board of Directors to fix their remuneration.”
VIEMED HEALTHCARE, INC. shareholders approved Election of seven director nominees.
“Shareholders elected each of the seven director nominees to serve until the next annual meeting of shareholders or until their successors are duly elected or appointed.”
VIEMED HEALTHCARE, INC. reported the three months ended March 31, 2026 results: revenue $75.4 million, net income $2.6 million, EPS $0.06 per diluted share. Guidance raised.
“and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): • Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025. • Net income attributable to Viemed for the”
VIEMED HEALTHCARE, INC. reported the three months and year ended December 31, 2025 results: revenue $76.2 million, net income $5.6 million, or $0.14 per diluted share, EPS $0.14 per diluted share. Guidance initiated.
“December 31, 2026. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): • Net revenues for the quarter ended December 31, 2025 were a company record $76.2 million, an increase of $15.5 million, or 26%, over net revenues reported for the comparable quarter ended December 31, 2024. Total net revenues for the year ended December 31, 2025 were”
Bruce Greenstein resigned as Director at VIEMED HEALTHCARE, INC..
“On April 14, 2025, Bruce Greenstein notified Viemed Healthcare, Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors, effective immediately.”
VIEMED HEALTHCARE, INC. reported three months ended March 31, 2024 results: revenue $50.6 million, net income $1.6 million.
“Net revenues for the quarter ended March 31, 2024 were $50.6 million , representing an increase of $11.0 million , or 28% , over net revenues reported for the comparable quarter ended March 31, 2023. • Net income for the quarter ended March 31, 2024 totaled $1.6 million.”
VIEMED HEALTHCARE, INC. reported the three months and year ended December 31, 2023 results: revenue $50.7 million, net income $3.5 million.
“and year ended December 31, 2023. Operational highlights (all dollar amounts are USD): • Net revenues for the quarter ended December 31, 2023 reached a new Company record of $50.7 million representing an increase of $13.2 million, or 35%, over net revenues reported for the comparable quarter ended December 31, 2022. Total net revenues for the year ended December”
VIEMED HEALTHCARE, INC. reported the three and nine months ended September 30, 2023 results: revenue $49.4 million, net income $2.9 million.
“months ended September 30, 2023. Operational highlights (all dollar amounts are USD): • Net revenues for the quarter ended September 30, 2023 reached a new Company record of $49.4 million, representing an increase of $13.6 million, or 38%, over net revenues reported for the comparable quarter ended September 30, 2022. This represents 14% sequential growth in”
VIEMED HEALTHCARE, INC. reported three and six months ended June 30, 2023 results: revenue $43.3 million, net income $2.3 million.
“highlights (all dollar amounts are USD): • Net revenues attributable to the Company's core business for the quarter ended June 30, 2023 reached a new Company record of $43.3 million, representing an increase of $10.2 million, or 31%, over core net revenues reported for the comparable quarter ended June 30, 2022. Net revenues for the quarter ended June 30,”
VIEMED HEALTHCARE, INC. shareholders approved Appointment of Ernst & Young LLP as auditors of the Company for the fiscal year ending December 31, 2023 and authorization of the Board to fix their remuneration. at the 2023-06-13 meeting.
“The shareholders approved the appointment of Ernst & Young LLP as auditors of the Company for the fiscal year ending December 31, 2023 and the authorization of the Board to fix their remuneration.”
VIEMED HEALTHCARE, INC. shareholders approved Election of eight directors to serve until the close of the next annual meeting of shareholders or until their successors are elected. at the 2023-06-13 meeting.
“Each of the eight nominees listed below were elected as directors of the Company to hold office until the next annual meeting of shareholders or until their successors are elected.”
VIEMED HEALTHCARE, INC. completed an acquisition involving Home Medical Products, Inc. for approximately $28 million in cash (closed 2023-06-01).
“HMP, Kevin Atkins and David Steele (collectively, the “Stockholders”). Viemed acquired from the Stockholders 100% of the equity ownership of HMP in exchange for approximately $28 million in cash, subject to customary post-closing net working capital and other adjustments. Approximately $15 million of the purchase consideration was funded by cash on hand, $8”
VIEMED HEALTHCARE, INC. reported three months ended March 31, 2023 results: revenue $39.6 million, net income $1.5 million.
“Operational highlights (all dollar amounts are USD): • Net revenues attributable to the Company's core business for the quarter ended March 31, 2023 were $39.6 million, a new Company record, and an increase of $9.4 million, or 31%, over the quarter ended March 31, 2022. Net revenues for the quarter ended March 31, 2023 were up approximately 6% over the quarter ended December 31, 2022. • Net income for the quarter ended March 31, 2023 totaled $1.5 million.”
VIEMED HEALTHCARE, INC. entered into Purchase Agreement with Home Medical Products, Inc., Kevin Atkins and David Steele valued at approximately $31.75 million in cash (effective 2023-04-18).
“On April 18, 2023, Viemed, Inc. ("Viemed"), a wholly-owned subsidiary of Viemed Healthcare, Inc. (the "Company"), entered into a definitive stock purchase agreement (the “Purchase Agreement”) with Home Medical Products, Inc., (“HMP”), Kevin Atkins and David Steele (collectively, the “Stockholders”), and David Steele, as the representative of the Stockholders, to acquire HMP for approximately $31.75 million in cash, subject to net working capital and other adjustments.”
VIEMED HEALTHCARE, INC. reported three months and year ended December 31, 2022 results: revenue Net revenues attributable to the Company's core business for the quarter ended December 31, 2022 were $37.5 million...To, net income Net income for the quarter and year ended December 31, 2022 totaled $2.4 million and $6.2 million, respectively.
“Net revenues attributable to the Company's core business for the quarter ended December 31, 2022 were $37.5 million”
VIEMED HEALTHCARE, INC. entered into Credit Agreement with Regions Bank, as administrative agent, and the lenders from time to time party thereto valued at up to $60 million (effective 2022-11-29).
“On November 29, 2022 (the “ Closing Date ”), Viemed, Inc. (the “ Borrower ”), and certain subsidiaries of the Borrower, as guarantors (the “ Guarantors ” and together with the Borrower, the “ Credit Parties ”), all wholly-owned subsidiaries of Viemed Healthcare, Inc. (the “ Company ”), entered into that certain credit agreement (the “ Credit Agreement ”) with the lenders from time to time party thereto (the “ Lenders ”) and Regions Bank, as administrative agent (the “ Administrative Agent ”) and collateral agent (the “ Collateral Agent ”).”
VIEMED HEALTHCARE, INC. reported financial results for the nine months ended September 30, 2022.
“issued a press release announcing its financial results for the three and nine months ended September 30, 2022.”
VIEMED HEALTHCARE, INC. reported the quarter ended September 30, 2022 results: revenue $35.8 million.
“Net revenues attributable to the Company's core business for the quarter ended September 30, 2022 were $35.8 million”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.